Search Results

You searched for : boehringer  

Dialogue with HighTide Therapeutics' CMO Dr. Filip Surmont: Moving Beyond the "Blockbuster" Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach

Across the landscape of global biotech companies, the appointment of a senior executive often serves as a "barometer"—offering insights into a company's pipeline ...
Apr 04

Equine Healthcare Market Set for Explosive Growth — Forecast to Reach $6.65 Billion by 2032 at CAGR: 8.1% with Rapid Innovation and Digital Transformation

Global Equine Healthcare Market is poised for remarkable expansion, fueled by rising global horse populations, breakthroughs in veterinary technology, and increased investment in equine health ...
Jan 21

IIM Bodh Gaya hosts Convergence 2.0: Re-imagining Healthcare Ecosystem with Technological Advancements

...
Sep 15

CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure.

...
May 20

Boehringer Ingelheim and Invetx collaborates to advance monoclonal antibody biotherapeutics in animal health

Latest pharma news update...
Sep 29

US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction

Latest Pharma News Update...
Aug 23

Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules, 100 mg and 150 mg

According to IQVIATM sales data for the 12 month period ending April 2021, the Ofev Capsules, 100 mg and 150 mg market achieved annual sales ...
Jun 25

FDA approves first oral blood thinning medicines for children

With the approval of Pradaxa, a blood-clotting medicine, pediatric patients have a good therapeutic option to treat and prevent potentially deadly blood clots....
Jun 22

Glenmark launches Tiogiva, becoming one of the first companies in the UK to launch a bioequivalent version of Tiotropium Bromide dry powder inhaler

Glenmark has launched Tiotropium Bromide Dry Powder Inhaler (DPI) under the brand name - Tiogiva in UK ...
Jun 15

Boehringer Ingelheim's Investigational Treatment for Schizophrenia receives FDA Breakthrough Therapy Designation

The company also announced the planned initiation of the innovative CONNEX Phase III clinical trial program assessing the safety and efficacy of BI 425809 ...
May 27

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type ...
Jan 07

Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules

Glenmark has received tentative approval by the United States Food & Drug Administration for Dabigatran Etexilate Capsules, the generic version of Pradaxa 1 Capsules...
Dec 21

Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial

...
Nov 19

New Analysis Supports Long-Term Treatment with nintedanib in SSc-ILD Patients1

New Analysis Supports Long-Term Treatment with nintedanib in SSc-ILD Patients1...
Nov 07

NIH study aims to identify promising COVID-19 treatments for larger clinical trials

Approximately 100 hospitalized volunteers will be assigned to each study arm with each of the study sites testing no more than three investigational treatments at ...
Oct 14

T-knife-Catalent sign Technology Transfer and Manufacturing Agreement for Cancer therapy

Manufacturing agreement for Autologous T-Cell Receptor-Based Cell Therapy...
Sep 24

Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets

Empagliflozin and Linagliptin tablets, have an estimated market size of US$ 244 million for twelve months ending June 2020...
Aug 27

Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets

Alembic receives USFDA approval for their erectile dysfunction drug ...
Aug 05

Boehringer Ingelheim expands free telemedicine platform to connect veterinarians

The PetPro Tele+ platform offers setup in minutes to enable virtual veterinary visits ...
May 19

BioMed X Institute launches Rapid Antiviral Response Platform for pandemics

BioMed X is an independent research institute located on the campus of the University of Heidelberg in Germany. ...
May 18

Boehringer Ingelheim Acquires Northern Biologics, Expanding Immuno-oncology Portfolio

Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio ...
May 16

Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease

European Medicines Agency (EMA) has adopted a positive opinion recommending granting marketing authorisation for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (...
Mar 03

Boehringer-Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox

Boehringer Ingelheim offers MyStudyWindow to provide patients, families, caregivers, and doctors consistent access to information about Boehringer Ingelheim’s actively recruiting studies conducted at global ...
Feb 20

Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing

Boehringer Ingelheim's pan-KRAS program promises preclinical data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, USA...
Oct 31

INBUILD® meets primary endpoint - study evaluated nintedanib in patients across a range of progressive fibrosing interstitial lung diseases1

New data showed positive effect of nintedanib on slowing decline of lung function in a broad range of fibrosing interstitial lung diseases with a progressive ...
Oct 01

25 Matching result(s) found!

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026